PMID: 2495150Jan 16, 1989Paper

Regional neuroleptic microinjections indicate a role for nucleus accumbens in lateral hypothalamic self-stimulation reward

Brain Research
J R Stellar, D Corbett

Abstract

Bilateral microinjections of the neuroleptic, cis-flupenthixol, were made into 56 forebrain targets distributed across various dopamine (DA) terminal fields in the forebrain. Drug effects on medial forebrain bundle (MFB) stimulation-produced reward were assessed with a rate-frequency procedure implemented in a runway paradigm in a discrete-trial fashion. This method generated independent measures of drug-induced changes in the MFB stimulation reward and operant motor/performance capacity. Control experiments were run with the inactive isomer, trans-flupenthixol. Results indicate a major role for accumbens DA in MFB reward, but not for the DA in caudate and medial frontal cortex. Few drug-induced motor/performance deficits were found at any site. In 14 selected subjects, 6-OHDA-induced chronic DA lesions were made at the same site as neuroleptic microinjection. These results confirmed the reward effects of acute DA receptor blockade, but produced a greater associated motor/performance impairment. Both behavioral effects of the lesion recovered within 2 weeks in many, but not all subjects.

References

Dec 1, 1978·Pharmacology, Biochemistry, and Behavior·K B Franklin
Jan 1, 1986·Physiology & Behavior·E MiliaressisD Coulombe
Jun 1, 1986·Behavioural Brain Research·C R Gallistel
Nov 1, 1974·Journal of Comparative and Physiological Psychology·J F MarshallP Teitelbaum
Nov 1, 1974·Journal of Comparative and Physiological Psychology·D E Edmonds, C R Gallistel
Jan 1, 1980·Pharmacology, Biochemistry, and Behavior·R A Wise
Feb 1, 1984·Brain Research Bulletin·R A Wise, M A Bozarth

❮ Previous
Next ❯

Citations

Oct 11, 2011·Psychopharmacology·Eric W FishC J Malanga
Jul 1, 1992·Pharmacology, Biochemistry, and Behavior·D Corbett
Aug 1, 1994·Pharmacology, Biochemistry, and Behavior·C S Maldonado-IrizarryA E Kelley
Feb 1, 1996·Pharmacology, Biochemistry, and Behavior·F S Hall, J R Stellar
Aug 1, 1997·Pharmacology, Biochemistry, and Behavior·J Yeomans, M Baptista
Dec 22, 1998·Brain Research. Brain Research Reviews·K C Berridge, T E Robinson
Aug 3, 2000·Brain Research Bulletin·M S TodtenkopfJ R Stellar
Jul 7, 2001·Behavioral Neuroscience·S SteidlJ S Yeomans
Jun 24, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Faïza BenaliouadPierre-Paul Rompré
Aug 1, 1992·Pharmacology & Toxicology·N F Ramsey, J M Van Ree
Apr 1, 1994·Journal of Basic and Clinical Physiology and Pharmacology·G Z Rosenstein
Dec 29, 2005·Proceedings of the National Academy of Sciences of the United States of America·Joseph F CheerR Mark Wightman
Mar 29, 2011·Annual Review of Neuroscience·Mariella De Biasi, John A Dani
May 26, 2015·Behavioural Brain Research·Lauren M ReynoldsCecilia Flores
Jan 1, 1993·Neuroscience and Biobehavioral Reviews·L L Bernardis, L L Bellinger
Feb 1, 1995·Journal of Clinical Psychopharmacology·N W WithersJ C Gillin
Feb 6, 2020·Current Pharmaceutical Design·Kenneth D Carr

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.